Vaccination with Rabies to Study the Humoral and Cellular Immune Response to a T-Cell Dependent Neoantigen in Man

Journal of Clinical Immunology

Volumn 23, Issue 6, 2003, Pages 528-538

  Brinkman, D M C ^a   Jol Van Der Zijde, C M ^a   Ten Dam, M M ^a   Vossen, J M ^a   Osterhaus, A D M E ^b   Kroon, F P ^a   Van Tol, M J D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antibody response; Immunization; Immunodeficiency; In vitro proliferation; Neoantigen; Rabies

Indexed keywords

ANTIGEN; DIPLOID CELL VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; RABIES VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; EVANESCENT GENERALIZED RASH; FEMALE; HEADACHE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VITRO STUDY; MALAISE; MALE; MOLECULAR RECOGNITION; MUSCLE; MYALGIA; PRIORITY JOURNAL; RABIES; RASH; SIDE EFFECT; T LYMPHOCYTE; VACCINATION; VOLUNTEER;

ADULT; ANTIBODIES; ANTIBODY FORMATION; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION SCHEDULE; MIDDLE AGED; RABIES VACCINES; T-LYMPHOCYTES; VACCINATION;

EID: 0842265769     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOCI.0000010429.36461.6b     Document Type: Article

References (46)

1. International Union of Immunological Societies. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Clin Exp Immunol 118 Suppl 1:1-28, 1999
2. Uytdehaag FG, Osterhaus AD, Loggen HG, Bakker RH, van Asten JA, Kreeftenberg JG, van der MP, van Steenis B: Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV). J Immunol 131:1234-1239, 1983
3. Perrin P, Joffret ML, Zanetti C, Bourhy H, Gontier C, Fritzell C, Leclerc C, Sureau P: Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees. Vaccine 9:549-558, 1991
4. Pyun KH, Ochs HD, Wedgwood RJ, Yang XQ, Heller SR, Reimer CB: Human antibody responses to bacteriophage phi X 174: Sequential induction of IgM and IgG subclass antibody. Clin Immunol Immunopathol 51:252-263, 1989
5. Weits J, de Gast GC, The TH, Esselink MT, Decider AM, Petrovic M, Mandema E: Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol 32:443-450, 1978
6. Korver K, Boeschoten EW, Krediet RT, van Steenis G, Schellekens PT: Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: Shift in some immunodeficiency states. Clin Exp Immunol 70:328-335, 1987
7. Briggs DJ, Dreesen DW, Morgan P, Chin JE, Seedle CD, Cryz L, Gluck R, Cryz SJ: Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults. Vaccine 14:1361-1365, 1996
8. Plotkin SA: Rabies. Clin Infect Dis 30:4-12, 2000
9. Thisyakorn U, Pancharoen C, Wilde H: Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination. Vaccine 19:1534-1537, 2001
10. Chutivongse S, Wilde H, Benjavongkulchai M, Chomchey P, Punthawong S: Postexposure rabies vaccination during pregnancy: Effect on 202 women and their infants. Clin Infect Dis 20:818-820, 1995
11. Jones RL, Froeschle JE, Atmar RL, Matthews JS, Sanders R, Pardalos J, Moeller L, Chin JE, Famula M, Briggs DJ, Lang J: Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: A randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine 19:4635-4643, 2001
12. Sabchareon A, Lang J, Attanath P, Sirivichayakul C, Pengsaa K, Le MV, Chantavanich P, Prarinyanuphab V, Pojjaroen-Anant C, Nimnual S, Wood SC, Riffard P: A new Vero cell rabies vaccine: Results of a comparative trial with human diploid cell rabies vaccine in children. Clin Infect Dis 29:141-149, 1999
13. WHO Expert Committee on Rabies: World Health Organ Tech Rep Ser 824:1-84, 1992
14. Cejka J, Mood DW, Kim CS: Immunoglobulin concentrations in sera of normal children: Quantitation against an international reference preparation. Clin Chem 20:656-659, 1974
15. van Wezel AL, van Steenis G, Hannik CA, Cohen H: New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Dev Biol Stand 41:159-168, 1978
16. Lyng J, Bentzon MW, Ferguson M, Fitzgerald EA: Rabies vaccine standardization: International collaborative study for the characterization of the fifth International Standard for Rabies Vaccine. Biologicals 20:301-313, 1992
17. Jefferis R, Reimer CB, Skvaril F, de Lange GG, Goodall DM, Bentley TL, Phillips DJ, Vlug A, Harada S, Radl J, Claassen E, Boersma JA, Coolen J : Evaluation of monoclonal antibodies having specificity for human IgG subclasses: Results of the 2nd IUIS/WHO collaborative study. Immunol Lett 31:143-168, 1992
18. Lyng J: Calibration of a replacement preparation for the International Standard for Rabies Immunoglobulin. Biologicals 22:249-255, 1994
19. Pullen GR, Fitzgerald MG, Hosking CS: Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 86:83-87, 1986
20. Rath S, Stanley CM, Steward MW: An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. J Immunol Methods 106:245-249, 1988
21. Luxton RW, Thompson EJ: Affinity distributions of antigen-specific IgG in patients with multiple sclerosis and in patients with viral encephalitis. J Immunol Methods 131:277-282, 1990
22. Korver K, Zeijlemaker WP, Schellekens PT, Vossen JM: Measurement of primary in vivo IgM-and IgG-antibody response to KLH in humans: implications of pre-immune IgM binding in antigen-specific ELISA. J Immunol Methods 74:241-251, 1984
23. Sagara J, Kawai A: Identification of heat shock protein 70 in the rabies virion. Virology 190:845-848, 1992
24. Bracci L, Ballas SK, Spreafico A, Neri P: Molecular mimicry between the rabies virus glycoprotein and human immunodeficiency virus-1 GP120: Cross-reacting antibodies induced by rabies vaccination. Blood 90:3623-3628, 1997
25. Martins TB, Jaskowski TD, Mouritsen CL, Hill HR: An evaluation of the effectiveness of three immunoglobulin G (IgG) removal procedures for routine IgM serological testing. Clin Diagn Lab Immunol 2:98-103, 1995
26. Bird P, Calvert JE, Amlot PL: Distinctive development of IgG4 subclass antibodies in the primary and secondary responses to keyhole limpet haemocyanin in man. Immunology 69:355-360, 1990
27. Ikematsu W, Kobarg J, Ikematsu H, Ichiyoshi Y, Casali P: Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation. J Immunol 161:2895-2905, 1998
28. Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535-541, 1973
29. Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, Dietzschold B: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287-292, 1994
30. Strady A, Lang J, Lienard M, Blondeau C, Jaussaud R, Plotkin SA: Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 177:1290-1295, 1998
31. Atanasiu P: Quantitative assay and potency test of antirabies serum and immunoglobulin. Monogr Ser World Health Organ 314-318, 1973
32. Briggs DJ, Schwenke JR: Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine 10:125-129, 1992
33. Rodrigues FM, Mandke VB, Roumiantzeff M, Rao CV, Mehta JM, Pavri KM, Poonawalla C: Persistence of rabies antibody 5 years after preexposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose. Epidemiol Infect 99:91-95, 1987
34. Aoki FY, Rubin ME, Fast MV: Rabies neutralizing antibody in serum of children compared to adults following postexposure prophylaxis. Biologicals 20:283-287, 1992
35. Lang J, Duong GH, Nguyen VG, Le TT, Nguyen CV, Kesmedjian V, Plotkin SA: Randomised feasibility trial of preexposure rabies vaccination with DTP-IPV in infants. Lancet 349:1663-1665, 1997
36. Ratanavongsiri J, Sriwanthana B, Ubol S, Phanuphak P: Cell-mediated immune response following intracutaneous immunisation with human diploid cell rabies vaccine. Asian Pac J Allergy Immunol 3:187-190, 1985
37. Phanuphak P, Khawplod P, Sirivichayakul S, Siriprasomsub W, Ubol S, Thaweepathomwat M: Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac J Allergy Immunol 5:33-37, 1987
38. Nicholson KG, Cole PJ, Turner GS, Harrison P: Immune responses of humans to a human diploid cell strain of rabies virus vaccine: Lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon. J Infect Dis 140:176-182, 1979
39. Ghaffari G, Passalacqua DJ, Bender BS, Briggs DJ, Goodenow MM, Sleasman JW: Human lymphocyte proliferation responses following primary immunization with rabies vaccine as neoantigen. Clin Diagn Lab Immunol 8:880-883, 2001
40. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D: Evidence for a viral super-antigen in humans. Nature 358:507-510, 1992
41. Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34-48, 1999
42. Sneller MC: Common variable immunodeficiency. Am J Med Sci 321:42-48, 2001
43. Ochs HD, Nonoyama S, Farrington ML, Fischer SH, Aruffo A: The role of adhesion molecules in the regulation of antibody responses. Semin Hematol 30:72-79, 1993
44. Claassen IJ, Osterhaus AD, Poelen M, Van Rooijen N, Claassen E: Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen, II. Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent. Immunology 94:455-460, 1998
45. Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, Chevailler A, Mouthon L, Weill B, Bruneval P, Kazatchkine MD, Kaveri SV: Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101:758-765, 2003
46. Schiff RI, Rudd C: Alterations in the half-life and clearance of IgG during therapy with intravenous gamma-globulin in 16 patients with severe primary humoral immunodeficiency. J Clin Immunol 6:256-264, 1986